NCT04921124View on ClinicalTrials.gov

Pharmacokinetic and PHarmacodynamic Analysis and Evaluation of Teriparatide (PTH 1-34) Between Sexes

PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 24, 2021

Primary Completion Date

July 5, 2021

Study Completion Date

July 9, 2021

Conditions
Stress Fracture
Interventions
DRUG

Teriparatide

PTH(1-34) cartridge and pen device

Trial Locations (1)

NR4 7UY

Norfolk and Norwich University Hospitals Foundation Trust, Norwich

All Listed Sponsors
collaborator

University of East Anglia

OTHER

collaborator

Ministry of Defence, United Kingdom

OTHER_GOV

lead

Norfolk and Norwich University Hospitals NHS Foundation Trust

OTHER